Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.260
-0.020 (-1.56%)
At close: Jan 21, 2026, 4:00 PM EST
1.270
+0.010 (0.80%)
After-hours: Jan 21, 2026, 7:30 PM EST
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $77.43 million as of January 21, 2026. Its market cap has decreased by -90.42% in one year.
Market Cap
77.43M
Enterprise Value
-103.90M
1-Year Change
-90.42%
Ranking
Category
Stock Price
$1.26
Market Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has decreased from $737.62M to $77.43M, a decrease of -89.50%. That is a compound annual growth rate of -32.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 78.66M | 4.92% |
| Dec 31, 2025 | 74.97M | -90.65% |
| Dec 31, 2024 | 801.44M | -26.12% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunic | 81.79M |
| CalciMedica | 80.98M |
| Korro Bio | 80.33M |
| Kazia Therapeutics | 79.54M |
| OKYO Pharma | 79.36M |
| Gain Therapeutics | 78.85M |
| Atossa Therapeutics | 78.79M |
| PolyPid | 78.18M |